Spinal Cord Injury Research Boosted by $3.1 Million in Grants

In Short Hills, New Jersey, the Christopher & Dana Reeve Foundation announced the awarding of three new spinal cord injury (SCI) research grants totaling $3.1 million on Wednesday. These funds will bolster clinical trial efforts and the development of research tools to expedite therapeutic discoveries for the treatment of SCI.

The foundation, a nonprofit organization committed to the eradication of spinal cord injury through the support of pioneering research, also works to enhance the lives of those affected by paralysis. Their financial contributions are seen as a vital impetus for scientific breakthroughs in the field.

The grants are directed toward two leading entities in neurological restoration and research. NeuroRestore, a center that combines innovative bioengineering and neurosurgical practices to reinstate neurological functions, has been chosen to receive two of the grants. Meanwhile, PsychoGenics, a specialized contract research organization concentrating on the central nervous system, has been awarded the third grant.

The funded projects are designed with the intent to revitalize SCI research by supplying necessary resources to further clinical trials. The aim is to swiftly augment the number of potential treatments and to overcome current barriers stalling ambitious research in SCI. Such an infusion of capital is anticipated to draw further progress and investment into this critical area of science.

Specifically, these trials will address chronic issues in the SCI community, including bladder dysfunction, which significantly affects the quality of life of affected individuals.

Source: ROI-NJ.com

LETS GET IN CONTACT

For immediate assistance, please call 855.586.2615
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • This field is for validation purposes and should be left unchanged.